Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glucocorticoid Antagonist Treatment for Tobacco Use Disorder

Trial Profile

Glucocorticoid Antagonist Treatment for Tobacco Use Disorder

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 15 Jan 2018

At a glance

  • Drugs Mifepristone (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 14 Nov 2017 Planned initiation date changed from 1 Nov 2017 to 1 Dec 2017.
    • 28 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top